University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 16 of 17

TERMINATED

Study Evaluating Genotypes Using Lucentis

NCT00474695
TERMINATED

Moderate Sedation Educational Software

NCT00708760
TERMINATED Phase 1

Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression

NCT00444236
TERMINATED NA

Liver Transplantation for Cholangiocarcinoma

NCT00708877
TERMINATED Phase 3

Aromatase Inhibitors in the Treatment of Male Infertility

NCT00440180
COMPLETED NA

Prospective Evaluation of Safety and Efficacy of Two Forms of Corneal Stromal Hydration

NCT00432874
COMPLETED

The Role of Erythropoietin in Myelodysplastic Syndrome

NCT00723112
COMPLETED NA

The Effect of BiosLife on Serum Lipids

NCT00457756
COMPLETED Phase 4

Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT

NCT00585182
COMPLETED

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

NCT00844129
COMPLETED NA

Reducing Cancer Disparities for American Indians in the Rural Intermountain West

NCT00380055
COMPLETED Phase 2

Myocardial Hemodynamic Effects of Levosimendan

NCT00585104
COMPLETED

Antecedents of Obesity: Fetal Measures of Adiposity

NCT00715754
COMPLETED

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

NCT01107327
TERMINATED Phase 2

Elucidation of Acid-Induced Pulmonary Inflammation

NCT00361972
COMPLETED

Cerebral Perfusion, Oxygenation, Electrical Activity

NCT00747682
COMPLETED

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

NCT00715247
COMPLETED

Heart Rate Variability in Children Conceived Via Assisted Reproductive Technologies

NCT00993369
COMPLETED Phase 2

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures

NCT00326612
TERMINATED

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

NCT00722254
COMPLETED

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00721864
COMPLETED

Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide

NCT00757146
COMPLETED NA

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

NCT00335491
COMPLETED Early Phase 1

Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

NCT00734279
COMPLETED

Intra-Abdominal Hypertension in Neonatal Intensive Care Patients

NCT00747552
COMPLETED

Effectiveness Study of Physical Therapy As an Adjunct to a Lumbar Therapeutic Selective Nerve Root Block

NCT00934284
COMPLETED

CRT Pilot Study for Children With Heart Failure

NCT00585065
COMPLETED NA

Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors

NCT00666250
COMPLETED

International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)

NCT01363596
COMPLETED Phase 1

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

NCT00346853
COMPLETED Phase 2

A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab

NCT00123630
COMPLETED

Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia

NCT00256529
COMPLETED Phase 1

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

NCT00707278
COMPLETED Phase 2

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

NCT00227266
TERMINATED Phase 2

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

NCT00707161
COMPLETED Phase 2

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

NCT00795886
COMPLETED Phase 4

Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel

NCT00131885
COMPLETED Phase 2

Pimecrolimus Cream for Oral Lichen Planus

NCT00297037
COMPLETED Early Phase 1

The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure

NCT00769210
COMPLETED

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

NCT00810784
COMPLETED NA

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

NCT00707174
COMPLETED Phase 1

Mind Engagement With Music for Nondrug Pain Relief

NCT00103870
COMPLETED Phase 2

Nondrug Treatment Programs for Adults With Fibromyalgia

NCT00088777
TERMINATED Phase 3

Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

NCT00113698
COMPLETED Phase 2

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

NCT02215538
COMPLETED

Evaluation of Information Displays-A Paper, Computer and Simulator Based Study

NCT00714012
COMPLETED Phase 2

Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis

NCT00297011
COMPLETED Phase 2

Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis

NCT00123656
COMPLETED

Syndactyly Repair: Comparison of Skin Graft and No Skin Graft Techniques

NCT01416090
COMPLETED Phase 2

A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer

NCT00585533
← Previous Page 16 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

Therapeutic Areas

Low Back Pain 8
Pain 8
Breast Cancer 8
Contraception 6
Stroke 6
Obesity 6
Metastatic Castration-Resistant Prostate Cancer 5
Gynecologic Cancer 4
Skin Cancer 4
Sleep 4

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.